51815-70-4

Basic information

• Product Name: Benzoic acid, 2-[[(acetyloxy)acetyl]amino]-
• CAS NO: 51815-70-4
• Molecular Formula: C11H11NO5
• Molecular Weight: 237.212
• Mol File: 51815-70-4.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: Benzoic acid, 2-[[(acetyloxy)acetyl]amino]-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 2-[[(acetyloxy)acetyl]amino]-(51815-70-4)
• EPA Substance Registry System: Benzoic acid, 2-[[(acetyloxy)acetyl]amino]-(51815-70-4)

Safety Data

• Hazardous Substances Data: 51815-70-4(Hazardous Substances Data)

Upstream product

• 52589-82-9 N-(hydroxyacetyl)anthranilic acid 
• 108-24-7 acetic anhydride 

Downstream Products

• 768368-46-3 2-acetoxymethyl-3-(4-nitrophenyl)-4-oxo-3,4-dihydroquinazoline 
• 20873-20-5 2-hydroxymethyl-3-phenyl-4-oxo-3,4-dihydroquinazoline 
• 54995-77-6 2-acetoxymethyl-3-(2-chlorophenyl)-4-oxo-3,4-dihydroquinazoline 
• 20873-19-2 2-acetoxymethyl-3-phenyl-4-oxo-3,4-dihydroquinazoline 
• 768368-45-2 2-acetoxymethyl-3-(4-methoxyphenyl)-4-oxo-3,4-dihydroquinazoline 
• 83759-23-3 2-hydroxymethyl-3-(2'-methoxy-4'-nitrophenyl)-4(3H)-quinazolinone 

Relevant articles and documents

Phosphodiesterase 4-inhibiting diazepinoindolones

The present invention presents compounds that inhibit phosphodiesterase 4 having Formula (I). The present invention also provides methods of using the compounds of Formula (I) to prevent or treat asthma, atopic dermatitis, rheumatoid arthritis, inflammatory bowel disorders, pulmonary hypertension, liver injury, bone loss, septic shock, or multiple sclerosis, and to pharmaceutical compositions that contain the compounds of Formula (I).

Methaqualone metabolites. Synthesis of two hydroxymethyl analogues of methaqualone. A quinazoline - benzodiazepine rearrangement

-